INTERIM PET/CT PREDICTS OUTCOMES OF DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) TREATED WITH FRONTLINE LENALIDOMIDE/RCHOP (R2CHOP): LONG‐TERM ANALYSIS OF MC078E
Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available
10.1002/hon.83_2880